Albany Molecular Res (AMRI)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 09-1998 | 06-1998 | 03-1998 | 12-1997 | 09-1997 | |
| Sales | 3,685 | 3,091 | 2,873 | 2,285 | 2,212 |
| Gross Profit | 3,685 | 3,091 | 2,873 | 2,285 | 2,212 |
| Operating Income | 3,685 | 3,091 | 2,873 | 2,285 | 2,212 |
| Pre-tax Income | 3,685 | 3,091 | 2,873 | 2,285 | 2,212 |
| Net Income Continuous | 2,004 | 2,758 | 4,539 | 50 | 1,555 |
| Net Income | $2,004 | $2,758 | $4,539 | $50 | $1,555 |
| EPS Basic Total Ops | 0.09 | 0.13 | 0.21 | 0.00 | 0.07 |
| EPS Basic Continuous Ops | 0.09 | 0.13 | 0.21 | 0.00 | 0.07 |
| EPS Diluted Total Ops | 0.08 | 0.12 | 0.19 | 0.00 | 0.07 |
| EPS Diluted Continuous Ops | 0.08 | 0.13 | 0.19 | 0.00 | 0.07 |
| EBITDA(a) | $3,685 | $3,091 | $2,873 | $2,285 | $2,212 |